Genome-wide expression analysis of therapy-resistant tumors reveals SPARC as a novel target for cancer therapy

Isabella T. Tai(BC Cancer Agency), Lan Bo Chen(Harvard University)

Journal of Clinical Investigation

May 14, 2005

10.1172/jci23002

Cited by 141

Related Papers

Periostin induction in tumor cell line explants and inhibition of in vitro cell growth by anti-periostin antibodies

|Carcinogenesis|2005|101

A Peptide of SPARC Interferes with the Interaction between Caspase8 and Bcl2 to Resensitize Chemoresistant Tumors and Enhance Their Regression In Vivo

|PLoS ONE|2011|57

Inactivation of the Kinase Domain of CDK10 Prevents Tumor Growth in a Preclinical Model of Colorectal Cancer, and Is Accompanied by Downregulation of Bcl-2

|Molecular Cancer Therapeutics|2017|23